Periscope Capital’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.5K Buy
125,000
+25,000
+25% +$5.72K ﹤0.01% 388
2025
Q4
$29.5K Hold
100,000
﹤0.01% 298
2025
Q3
$29K Hold
100,000
﹤0.01% 241
2025
Q2
$29.1K Hold
100,000
0.01% 191
2025
Q1
$25.5K Buy
+100,000
New +$17.6K 0.01% 150

Other funds holding TDACW

Periscope Capital's TDACW Position: Q1 2026 in Review

Periscope Capital increased its Translational Development Acquisition Corp Warrants (TDACW) stake by 25% in Q1 2026, buying an estimated $5.72K and bringing the position to 125,000 shares worth $17.5K. The position accounts for ﹤0.01% of the portfolio, ranked #388.

Periscope Capital first reported a position in TDACW in Q1 2025 and has held it in 5 quarters since. The position peaked at $29.5K in Q4 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.

  • Periscope Capital held 125,000 shares of Translational Development Acquisition Corp Warrants worth $17.5K as of Q1 2026.
  • Periscope Capital bought 25,000 Translational Development Acquisition Corp Warrants shares in Q1 2026, an estimated $5.72K.
  • Translational Development Acquisition Corp Warrants made up ﹤0.01% of Periscope Capital's portfolio in Q1 2026, its #388 holding.
  • Periscope Capital first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 5 quarters since.
  • Periscope Capital's Translational Development Acquisition Corp Warrants position peaked at $29.5K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.

Based on Periscope Capital's 13F filing for Q1 2026, filed 14 May 2026.